Cargando…
Folate Receptor-Mediated Enhanced and Specific Delivery of Far-Red Light-Activatable Prodrugs of Combretastatin A-4 to FR-Positive Tumor
[Image: see text] We examined the concept of a novel prodrug strategy in which anticancer drug can be locally released by visible/near IR light, taking advantage of the photodynamic process and photo-unclick chemistry. Our most recently formulated prodrug of combretastatin A-4, Pc-(L-CA4)(2), showed...
Autores principales: | Nkepang, Gregory, Bio, Moses, Rajaputra, Pallavi, Awuah, Samuel G., You, Youngjae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275160/ https://www.ncbi.nlm.nih.gov/pubmed/25351441 http://dx.doi.org/10.1021/bc500376j |
Ejemplares similares
-
Far-Red Light Activatable,
Multifunctional Prodrug
for Fluorescence Optical Imaging and Combinational Treatment
por: Bio, Moses, et al.
Publicado: (2014) -
Folate-PEG Conjugates of a Far-Red Light-Activatable
Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive
Cancer Cells
por: Thapa, Pritam, et al.
Publicado: (2017) -
A generator of peroxynitrite activatable with red light
por: Parisi, Cristina, et al.
Publicado: (2021) -
Red-Light-Activatable AND-Gated Antitumor Immunosuppressant
por: Zhou, Ziqi, et al.
Publicado: (2023) -
In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)